MoneyWorks4Me

Emmessar Biotech&Nut - Quaterly Results

21 May 2022 Evaluate
The Sales for the quarter ended March 2022 of Rs. 1.46 million declined by -96.77% from Rs. 45.21 millions.The company suffered a huge decline of -93.40% to Rs. 0.34  millions from Rs. 5.15 millions  of corresponding previous quarter.Operating profit for the quarter ended March 2022 decreased to 5.27 millions as compared to 13.40 millions of corresponding quarter ended March 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 1.46 45.21 -96.77 3.65 69.91 -94.78 3.65 69.91 -94.78
Other Income 7.06 3.63 94.49 19.19 14.66 30.90 19.19 14.66 30.90
PBIDT 5.27 13.40 -60.67 10.25 23.12 -55.67 10.25 23.12 -55.67
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT 5.27 13.40 -60.67 10.25 23.12 -55.67 10.25 23.12 -55.67
Depreciation 0.37 0.15 146.67 0.92 0.58 58.62 0.92 0.58 58.62
PBT 4.90 13.25 -63.02 9.33 22.54 -58.61 9.33 22.54 -58.61
TAX 4.56 8.10 -43.70 4.57 8.05 -43.23 4.57 8.05 -43.23
Deferred Tax 0.22 4.48 -95.09 0.22 4.48 -95.09 0.22 4.48 -95.09
PAT 0.34 5.15 -93.40 4.76 14.49 -67.15 4.76 14.49 -67.15
Equity 49.96 49.96 0.00 49.96 49.96 0.00 49.96 49.96 0.00
PBIDTM(%) 360.96 29.64 1117.83 280.82 33.07 749.15 280.82 33.07 749.15
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..